any hostile takeover attempt (nor is the Board currently aware of any such attempts directed at the Company), nevertheless, stockholders should be aware that approval of this Proposal No. 3 could facilitate future efforts by the Company to deter or prevent changes in control of the Company, including transactions in which the stockholders might otherwise receive a premium for their shares over then current market prices.
The full text of the operative provisions of the form of Certificate of Amendment to Amended and Restated Certificate of Incorporation that the Board is recommending for adoption by the stockholders is attached hereto as Exhibit A. The text of the Company’s existing Amended and Restated Certificate of Incorporation, and all amendments thereto, may be obtained upon written request directed to the Company’s Secretary at its principal office set forth on the notice of Annual Meeting accompanying this proxy statement. The Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as any amendments to those reports, are available free of charge through the SEC’s at www.sec.gov. Stockholders may also read and copy materials that the Company files with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, DC 20549. Stockholders may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.
In connection with the Transaction described in Proposal No. 4, the Company entered into a voting agreement with each of Leigh S. Belden, a member of the Company’s Board of Directors and the Company’s President and Chief Executive Officer, and Beltech, Inc., a corporation of which Mr. Belden is a Director and President. Pursuant to the terms of the voting agreement, each party has agreed to vote any shares of the Company’s capital stock held by it to, among other things, approve this Proposal No. 3 and approve the issuance of Common Stock as described in Proposal No. 4.
The affirmative vote of the holders of a majority of the outstanding shares of the Common Stock will be required to approve this amendment to the Company’s Amended and Restated Certificate of Incorporation. As a result, abstentions and broker non-votes will have the same effect as negative votes. Under rules of the Nasdaq Stock Market, most brokers will have discretionary voting power with respect to Proposal No. 3 to vote shares held by them in “street name” unless instructed by beneficial owners of those shares.
PROPOSAL NO. 4
APPROVAL OF THE ISSUANCE OF COMMON STOCK
IN CONNECTION WITH A FINANCING TRANSACTION
The following description of the principal terms of the transaction and the securities already issued and to be issued is a summary of the material terms of the financing agreements only. You should read the complete text of each of the agreements relating to this transaction, which are filed as exhibits to the Company’s Current Report on Form 8-K/A filed with the Securities and Exchange Commission, or SEC, on April 19, 2005.
Background
On March 20, 2005, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with the investors identified on the Schedule of Buyers attached thereto, pursuant to which it issued and sold in a private placement (the “Transaction”) an aggregate of $10,000,000 in principal amount of senior secured convertible notes (the “Initial Notes”), warrants to purchase up to 830,563 shares of the Company’s Common Stock (the “Warrants”), and additional investment rights to purchase up to an aggregate of $5,000,000 in principal amount of additional Notes (the “Additional Notes” and, collectively with the Initial Notes, the “Notes”). The private placement closed on March 21, 2005. The Company used approximately $3.5 million of the proceeds from the private placement to repay all amounts outstanding under its revolving line of credit with RBC Centura Bank.
The Notes bear interest at a rate of six percent per annum payable in arrears for each calendar quarter on the tenth day of the succeeding calendar quarter beginning on July 10, 2005, and the Initial Notes must be repaid in $1,000,000 quarterly installments beginning on July 10, 2005 and ending October 10, 2007. The Notes mature on March 21, 2008. The Initial Notes are initially convertible into an aggregate of 3,322,259 shares of Common Stock based on an initial conversion price of $3.01 per share. Pursuant to Amendment Agreements dated October 31, 2005 (the “Amendments”) with each of the holders of the Initial Notes, Warrants, and additional investment rights, the conversion price of the Additional Notes was reduced to $1.00 per share and the Company extended the expiration of the holders’ right to exercise their additional investment rights to June 29, 2006. If Additional Notes are issued upon the exercise of the additional investment rights, those Additional Notes would be convertible into an additional 5,000,000 shares of Common Stock based upon the $1.00 per share conversion price. The conversion price of the currently outstanding $8 million principal amount of Initial Notes is $3.01 per share and has not been amended. The conversion price for the Notes is subject to broad-based anti-dilution provisions in connection with certain future issuances of securities of the Company as well as for adjustments for stock splits and the like.
The Warrants are exercisable at any time on or after September 21, 2005 through March 21, 2010. The Warrants were issued with an exercise price of $3.41 per share, which was reduced to $.93 per share (the “Exercise Price”) pursuant to the Amendments, and are subject to broad-based anti-dilution provisions similar to the provisions set forth in the Notes. If the exercise price of the Warrants is adjusted, the number of shares of Common Stock issuable upon exercise of the Warrants will be adjusted correspondingly.
Why the Company Needs Stockholder Approval
Because the Company’s Common Stock is listed on the Nasdaq National Market, it is subject to the Nasdaq Marketplace Rules. Rule 4350(i) of the Nasdaq Marketplace Rules requires stockholder approval for any issuance of stock, other than a public offering, at a price below the greater of book or market value of the stock, where the issuance or potential issuance of stock would equal 20% or more of the total number of the outstanding shares of Common Stock or 20% or more of the total voting power outstanding immediately prior to the issuance.
On March 18, 2005, the last trading day prior to the date of the Purchase Agreement, the closing bid price of the Company’s Common Stock on the Nasdaq National Market was $2.62 per share. When issued, the Notes had an initial conversion price of $3.01 per share and the Warrants had an initial exercise price of $3.41 per share. Assuming no adjustments are made to the conversion prices of the Notes and the Exercise Price of the Warrants, the Common Stock issuable upon the conversion of the Notes and the exercise of the Warrants would be issued at prices
22
that are higher than the greater of the market or book value of the Common Stock as of the date of the Purchase Agreement and the applicable Nasdaq Marketplace Rules would not be implicated by such issuances. However, certain future issuances of the Company’s equity securities may cause anti-dilution adjustments to the conversion prices of the Notes and the Exercise Price of the Warrants such that the per share price for which the shares of Common Stock issuable pursuant to the Notes and the Warrants could be less than the greater of the market value and the book value of the Company’s Common Stock as of the date of the Purchase Agreement.
Pursuant to the terms of the Notes, the Company will have the option, subject to certain limitations, to satisfy its interest and installment payment obligations under the Notes by the delivery of shares of Common Stock at a price equal to 90% of the arithmetic average of the volume-weighted average sale price of the Common Stock for the fifteen consecutive trading days ending on the fourth trading day immediately preceding the applicable interest or amortization payment date. In addition to regularly scheduled installment payments, if, as of the end of each fiscal quarter, the Company fails to maintain certain minimum working capital requirements, the holders of the Notes may require the Company to make an additional installment payment under the Notes which shall be, at the option of each holder, such holder’s pro rata portion of one of the following: (i) the difference between (A) the unpaid principal, interest and any late charges then remaining under the Notes and (B) 60% of the Company’s working capital amount, as determined in accordance with the terms of the Notes, (ii) $2,000,000 or (iii) any lesser amount specified by such holders. The payment of any such additional installment amounts may also be paid, at the Company’s option, by the delivery of shares of Common Stock calculated using the same conversion price formula set forth above for regularly scheduled installment amounts. The Company’s ability to elect to pay installment amounts or interest in shares of Common Stock is subject to conditions relating to the registration of the shares to be issued, compliance with the effective minimum listing maintenance requirements of the Nasdaq National Market and certain other conditions set forth in the Notes. The Nasdaq Marketplace Rules generally require the Company to maintain a minimum bid price per share of $1.
An indeterminate number of shares of the Company’s Common Stock could be issuable upon conversion of the Notes and exercise of the Warrants due to the potential for anti-dilution adjustments to the conversion prices of the Notes and the Exercise Price of the Warrants and in satisfaction of the Company’s obligations to pay interest and installment amounts under the Notes. In determining whether stockholder approval would be required under Rule 4350(i), Nasdaq looks to the hypothetical maximum number of shares that could potentially be issued and the minimum price per share for which such shares could potentially be issued. Since the issuance of Common Stock underlying the Notes and the Warrants, whether upon a conversion or in connection with an interest or installment payment, could be effected at a per share price less than the greater of the market value and the book value of the Company’s Common Stock as of the date of the Purchase Agreement and the number of shares of Common Stock issuable upon conversion of the Notes or exercise of the Warrants, respectively, could equal or exceed 20% of the Company’s outstanding Common Stock, stockholder approval would be required prior to any such issuance of 20% or more of the Company’s outstanding Common Stock. Accordingly, the Company is seeking stockholder approval at this time in advance of any such issuance of Common Stock.
Rule 4350 also requires companies that are listed on Nasdaq to obtain stockholder approval prior to issuing common stock if such issuance will result in a change of control of the issuer. Nasdaq may consider a number of factors in determining whether a change of control will occur as a result of a particular transaction, the most significant of which is an investor’s post-transaction ownership and/or voting power. Specifically, a change in control is deemed to occur when the ownership by any stockholder or group of affiliated stockholders equals or exceeds 20% or more of an issuer’s voting stock immediately following the issuance. The Company agreed in the Purchase Agreement to seek such stockholder approval at this, and to hold an additional stockholder meeting each calendar quarter thereafter until such stockholder approval is obtained. Consistent with Rule 4350, the Notes and the Warrants respectively provide that the Notes may not be converted, and the Warrants may not be exercised, into more than 20% of the number of shares or voting power of the Company’s Common Stock outstanding as of the closing of the financing until and unless this Proposal No. 4 is approved by the stockholders.
As a condition to consummating the Transaction, the Company agreed to seek stockholder approval of the matters set forth in Proposal No. 3 and this Proposal No. 4 at a meeting held no later than November 21, 2005, which has been extended until December 16, 2005 pursuant to the Amendments. If stockholder approval is not obtained on or prior to this deadline, the Company is obligated to seek stockholder approval during each calendar quarter thereafter until such stockholder approval is obtained.
23
If this Proposal No. 4 is not approved, the Company may not be able to deliver shares of Common Stock as payment of interest or an installment amount without violating Nasdaq Marketplace Rule 4350(i). In order to avoid violating such rule, the Company would have to make at least 50% of its interest and installment payments pursuant to the Notes due after such date in cash until such time as this Proposal is so approved. This requirement would limit the Company’s flexibility in deciding whether it will satisfy these obligations in cash or Common Stock based on market conditions and the best interests of its stockholders at the time of such payments. Additionally, having to make payments in cash where it would otherwise be optimal for the Company to satisfy these obligations with the delivery of shares of Common Stock could leave the Company with insufficient working capital to operate its business. If the Company has insufficient working capital to operate its business, the Company may be forced to seek additional financing on terms which could materially and adversely affect the interests of its stockholders at that time. In the event that this Proposal No. 4 is not approved by the stockholders, the Company may be further limited in its ability to obtain future financing in that it may not, pursuant to the terms of the Purchase Agreement, be able to issue or sell securities of the Company below the conversion prices of the Notes or the Exercise Price of the Warrants.
If this Proposal No. 4 is approved and a future dilutive transaction were to occur, the conversion prices of the Notes and the Exercise Price of the Warrants would be adjusted and, as a result, the issuance of Common Stock upon a future conversion of the Notes or exercise of the Warrants could potentially result in substantial dilution to the voting interests of the Company’s existing stockholders and those stockholders will own a smaller percentage of the Company’s outstanding Common Stock as a result of such issuances.
Terms of the Private Placement
In addition to the terms and conditions described above, the holders of the Notes and the Warrants were granted the following rights pursuant to the private placement:
Notes. An event of default will occur under the Notes in certain circumstances, including among other things the Company’s failure to pay when due any principal or interest on the Notes, certain defaults on the Company’s indebtedness, certain events of bankruptcy and the Company’s breach or failure to perform in respect of representations and obligations under the Notes. Upon an “event of default” (as defined in the Notes), the holders of the Notes may require the Company to redeem all or any portion of the Notes. The redemption amount shall equal the greater of (i) 120% (or 100% in the case of an event of default triggered under certain bankruptcy laws) of the unpaid principal, interest and any late charges then remaining under the Notes subject to redemption or (ii) the closing sale price of the Company’s Common Stock on the trading day immediately prior to the date of the event of default multiplied by the number of shares of Common Stock issuable upon the conversion of the portion of the Notes subject to redemption at the then-effective conversion prices.
Subject to certain conditions, at any time after April 18, 2006, if the weighted average price of the Company’s Common Stock equals or exceeds 200% of the then current conversion prices of the Notes for a specified period, and certain other conditions are satisfied, the Company will have the right to convert all of the unpaid principal, interest and any late charges then remaining under the Notes plus the discounted present value of any remaining future interest payments under the Notes into shares of Common Stock at the then-applicable conversion prices of the Notes or, at the Company’s option solely with respect to the present value of future interest payments, cash or a combination of Common Stock and cash.
Upon a change of control (as defined in the Notes), the Holders may require the Company to repurchase some or all of their Notes at a price in cash equal to the greater of (i) the product of (x) the conversion amount being redeemed and (y) the quotient determined by dividing (a) the closing sale price of the Common Stock immediately following the public announcement of such proposed change of control by (b) the conversion price and (ii) the product of (x) the applicable change of control premium and (y) the conversion amount being redeemed (as such terms are defined in the Notes).
Registration Rights. Under the terms of the Registration Rights Agreement entered into in connection with the Transaction, the Company has filed a registration statement (the “Registration Statement”) with the Securities and Exchange Commission to register the resale of the shares of its Common Stock issuable upon the conversion of the Notes issued at the initial closing, the shares of Common Stock issuable upon exercise of the Warrants, the shares of Common Stock issuable in payment of interest obligations under the Notes issued at the initial closing, and
24
any shares of the Company’s stock issuable on or in exchange for such shares, which Registration Statement was declared effective by the SEC on April 18, 2005. Additionally, following each exercise of additional investment rights to purchase an aggregate of at least $500,000 in principal amount of the Notes issuable thereunder, and upon the exercise of the last of any remaining additional investment rights, the Company is obligated to file a registration statement with the SEC to register the resale of the shares of its Common Stock issuable upon the conversion of the Notes issued in connection with such exercise, plus any shares issued as payment of interest thereon, within 30 days after each such Note issuance. Each such additional registration statement is required under the agreement to become effective within 90 days following the exercise of each applicable additional investment right (or, if there is a full review of the registration statement, within 120 days following the exercise of the applicable additional investment right). In the event that the Company fails to timely register, or maintain the effectiveness of, any registration statement in accordance with the terms of the Registration Rights Agreement, it will be required to pay to each holder, on the date on which such failure occurs and each thirty day anniversary thereafter during which such failure is continuing, an amount in cash equal to one percent of the aggregate purchase price of such securities held by the holder included in such Registration Statement (or, in the case of a failure to timely register a sufficient number of shares of Common Stock under, or to maintain the effectiveness of, an effective Registration Statement, cash equal to one percent of the greater of (i) one-third of the aggregate purchase price of the securities or (ii) the purchase price only of such securities that cannot be sold as a result of such failure).
Security Agreement and Guaranties. The Company’s obligations under the Notes are secured by a lien on substantially all of the Company’s assets in favor of Portside Growth & Opportunity Fund, as collateral agent for the investors in the Transaction, pursuant to the Pledge and Security Agreement entered into on March 21, 2005 in connection with the private placement. Additionally, Larscom Incorporated and Verilink Europe Limited, each wholly-owned subsidiaries of the Company, have guaranteed the Company’s obligations under the financing agreements pursuant to the Guaranty entered into on March 21, 2005 by the Company, Portside Growth & Opportunity Fund and such subsidiaries.
Purchase Agreement. The investors in the Transaction have subscription rights in respect of certain future issuances by the Company of its debt or equity securities occurring prior March 21, 2007. If the Company determines to issue any such securities not subject to certain exceptions set forth in the Purchase Agreement, then it must provide notice to the investors and offer to sell to each investor its pro rata amount of 30% of such securities, on the same terms it proposes to sell such securities to other investors, based on the principal amount of the notes purchased by the investor pursuant to the Purchase Agreement.
Voting Agreements. In connection with the Transaction, the Company entered into a voting agreement with each of Leigh S. Belden, a member of the Company’s Board of Directors and the Company’s President and Chief Executive Officer, and Beltech, Inc., a corporation of which Mr. Belden is a Director and President. Pursuant to the terms of the voting agreement, each party has agreed to vote any shares of the Company’s capital stock held by it to, among other things, approve this Proposal No. 4 and approve the increase in the Company’s authorized capital as described in Proposal No. 3.
Rights Agreement. In November 2001, the Company entered into a Rights Agreement with Equiserve Trust Company, N.A., the Company’s transfer agent at such time, as amended by the Rights Agent Appointment and Amendment No. 1 to Rights Agreement (appointing American Stock Transfer and Trust Company as rights agent) and the Amendment No. 2 to Rights Agreement (collectively, the Rights Agreement). In connection with the Transaction, on March 20, 2005, the Company entered into an Amendment No. 3 to Rights Agreement with American Stock Transfer and Trust Company to provide that the Notes, the Warrants and the additional investment rights to be issued in connection with the Transaction will not be deemed “beneficially owned” by their holders for the purposes of the Rights Agreement, including the determination of whether or not a person has become an “acquiring person” under the Rights Agreement.
Anti-dilution Provisions of the Notes and the Warrants. If the Company issues or sells, or pursuant to the Notes and Warrants is deemed to have issued or sold, any shares of Common Stock (excluding certain issuances or sales described below) for a price per share less than the conversion price (in the case of the Notes) or the Exercise Price (in the case of the Warrants) in effect immediately prior to such issue or sale (a “Dilutive Issuance”), then immediately after such Dilutive Issuance, the conversion prices or the Exercise Price (or both) then in effect shall be reduced to an amount equal to the product of (A) the conversion price or the Exercise Price, respectively, in effect immediately prior to such Dilutive Issuance and (B) the quotient determined by dividing (1) the sum of (I) the
25
product derived by multiplying the conversion price or the Exercise Price, respectively, in effect immediately prior to such Dilutive Issuance and the number of shares of Common Stock deemed outstanding immediately prior to such Dilutive Issuance plus (II) the consideration, if any, received by the Company upon such Dilutive Issuance, by (2) the product derived by multiplying (I) the conversion price or the Exercise Price, respectively, in effect immediately prior to such Dilutive Issuance by (II) the number of shares of Common Stock deemed outstanding immediately after such Dilutive Issuance.
In addition, in the case of the Warrants, upon an adjustment of the Exercise Price as described above, the number of shares of Common Stock received upon exercise of the Warrants shall be adjusted to the number of shares of Common Stock determined by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares of Common Stock acquirable upon exercise of the Warrant immediately prior to such adjustment and dividing the product thereof by the Exercise Price resulting from such adjustment.
The anti-dilution provisions above do not apply to certain “excluded securities,” including securities issued in connection with employee benefit plans, upon conversion of the Notes or the exercise of the Warrants, as payment of interest on the Notes, pursuant to certain underwritten public offerings, pursuant to certain acquisitions by the Company, or upon the conversion of certain options or convertible securities.
Vote Required
The affirmative vote of a majority of the shares of Common Stock present in person or represented by proxy and voting at the Special Meeting will be required to approve this Proposal No. 4. Abstentions will have the same effect as an “Against” vote. Broker non-votes are not counted for any purpose in determining whether this proposal has been approved.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE ISSUANCE OF COMMON STOCK IN CONNECTION WITH A FINANCING TRANSACTION.
26
STOCKHOLDER PROPOSALS/STOCKHOLDER NOMINATIONS FOR DIRECTOR
Stockholder proposals submitted pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and intended to be presented at the Company’s 2006 Annual Meeting of Stockholders must be received by the Company not later than July 6, 2006 in order to be considered for inclusion in the Company’s proxy materials for that meeting.
The Board of Directors does not currently have a nominating committee or a committee performing the functions of a nominating committee. Stockholders wishing to directly nominate candidates for election to the Board of Directors (“Director Nominations”) and for the conduct of other business to be brought before an annual meeting (“Other Business”), must do so in accordance with the Company’s Certificate of Incorporation and Bylaws.
To be timely, notice of Director Nominations to be brought before an annual meeting or special meeting must be received by the Company, at the address set forth below, not earlier than ninety nor later than sixty days prior to the first anniversary of the preceding year’s annual meeting or, if the date of the annual meeting is advanced by more than thirty days or delayed by more than sixty days from such anniversary, such notice must be received not earlier than ninety days prior to such annual meeting and not later than the later of (1) the sixtieth day prior to the annual meeting or (2) the tenth day following the date on which notice of the date of the annual meeting was mailed or public disclosure thereof was made, whichever occurs first. The Certificate of Incorporation also provides that notice of Director Nominations of any candidate for director shall include certain information with respect to a proposed nominee, including (without limitation) information as to such nominee’s business background, relationships with stockholders and certain other parties, and share ownership in the Company.
To be considered by the independent directors, a Director Nomination must comply with the requirements for a stockholder proposal specified in the SEC’s Rule 14a-8 and must be accompanied by a written statement from the proposed candidate that he or she is willing to be nominated and desires to serve, if elected.
To be timely, notice of Other Business to be brought before an annual meeting or special meeting must be received by the Company, at the address set forth below, not later than ninety days prior to the meeting date or, if less than one hundred days notice or prior public disclosure of the date of the meeting is given to or made to stockholders, notice of Other Business must be received no later than the close of business on the tenth day following the day on which such notice of the date of the annual meeting or special meeting was mailed or made public.
Stockholder proposals for Other Business or Director Nominations should be mailed to C.W. Smith, Vice President, Corporate Controller and Secretary, Verilink Corporation, 127 Jetplex Circle, Madison, Alabama 35758-8989.
HOUSEHOLDING OF PROXY MATERIALS
The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies.
This year, a number of brokers with account holders who are Verilink Corporation stockholders will be “householding” the Company’s proxy materials. A single proxy statement will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be “householding” communications to your address, “householding” will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in “householding” and would prefer to receive a separate proxy statement and annual report, please notify your broker; direct your written request to 127 Jetplex Circle, Madison, Alabama 35758-8989, Attn: Corporate Secretary or contact C. W. Smith, Vice President, Corporate Controller and Secretary, at 256.327.2204. Stockholders who currently receive multiple copies of the proxy statement at their address and would like to request “householding” of their communications should contact their broker.
27
OTHER MATTERS
The Board of Directors knows of no other business at this time which will be presented to the Annual Meeting. If any other business is properly brought before the Annual Meeting, it is intended that proxies in the enclosed form will be voted in respect thereof in accordance with the judgments of the persons voting the proxies.
It is important that the proxies be returned promptly and that your shares be represented. Stockholders are urged to fill in, sign and promptly return the accompanying form in the enclosed envelope.
| By Order of the Board of Directors, |
| |
| 
|
| Leigh S. Belden |
| President, Chief Executive Officer and Director |
November 4, 2005
Centennial, Colorado
28
EXHIBIT A
CERTIFICATE OF AMENDMENT TO AMENDED
AND RESTATED CERTIFICATE OF INCORPORATION
Paragraph A of Article FOURTH of the Corporation’s Amended and Restated Certificate of Incorporation shall be amended and restated to read in its entirety as follows:
“ A. The total number of shares of all classes of stock which the Corporation shall have authority to issue is sixty-one million (61,000,000), consisting of:
(1) one million (1,000,000) shares of Preferred Stock, par value one cent ($.01) per share (the “Preferred Stock”); and
(2) sixty million (60,000,000) shares of Common Stock, par value one cent ($.01) per share (the “Common Stock”). “
A-1

A-2
[FORM OF FRONT OF PROXY CARD]
PROXY
VERILINK CORPORATION
11551 E. Arapahoe Road, Suite 150
Centennial, Colorado 80112-3833
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS FOR THE ANNUAL MEETING OF STOCKHOLDERS ON NOVEMBER 30, 2005
The undersigned hereby appoints LEIGH S. BELDEN and TIMOTHY R. ANDERSON as Proxies, or either of them, with full power of substitution, and hereby authorizes them to vote, as designated below, all shares (unless a lesser number is specified on the other side) of Common Stock of Verilink Corporation (the “Company”) that the undersigned would be entitled to vote at the Annual Meeting of Stockholders of the Company to be held on November 30, 2005 at the Company’s offices at 11551 E. Arapahoe Road, Suite 150, Centennial, Colorado 80112-3833 at 9:00 a.m. local time, and any adjournment or postponement thereof.
| The shares represented by this proxy will be voted as directed by the undersigned stockholder. If no direction is given, such shares will be voted FOR each of Proposals 1 through 4 and in the discretion of the proxy holder(s) with respect to other matters properly brought before the meeting, including any adjournments thereof. |
(Continued and to be SIGNED on the Next Page)
A-3
The Board of Directors recommends a vote FOR each of Proposals 1, 2, 3 and 4.
| | | | | | | | | Please mark and date the proxy and sign your name as it appears hereon. If executed by a corporation, a duly authorized officer must sign by name and title. Executors, administrators, and trustees must so indicate when signing. If shares are held jointly, EACH holder must sign. |
| | | | | | | | | |
| | | | | | | | | Dated | ______________________________, 2005 |
| | | | | | | | | |
| | | | | | | | | _______________________________________ |
| | | | | | | | | |
| | | | | | | | | _______________________________________ |
| | | | | | | | | Signature(s) of Stockholder(s) |
No. 1 | | Proposal to elect Leigh S. Belden and Steven C. Taylor as Class III directors of the Company. | | |
| | | | | | | | | |
| | For | | Withheld | | | | |
| | | | | | (INSTRUCTION: To withhold authority to vote for any individual nominee, write that nominee’s name in the space provided below.) | | |
| | o | | o | | | |
| | | | | | | | |
| | | | | |
| | |
| | | | | | | | | |
No. 2 | | Proposal to ratify and approve the appointment of Ehrhardt Keefe Steiner & Hottman PC as the Company’s independent registered public accounting firm for the 2006 fiscal year. | | |
| | | | | | | | | |
| | For | | Against | | Abstain | | | |
| | | | | | | | | |
| | o | | o | | o | | | |
| | | | | | | | | |
| | | | | | | | | |
No. 3 | | Proposal to approve the amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 60,000,000 shares. | | |
| | | | | | | | | |
| | For | | Against | | Abstain | | | |
| | | | | | | | | |
| | o | | o | | o | | | |
| | | | | | | | | |
No. 4 | | Proposal to approve the potential issuance of shares of common stock (i) upon the conversion of convertible notes and the exercise of warrants issued and issuable pursuant to a private financing completed in March 2005 and (ii) in satisfaction of certain principal and interest payment obligations under such convertible notes. | | |
| | | | | | | | | |
| | For | | Against | | Abstain | | | |
| | | | | | | | | |
| | o | | o | | o | | | |